CIK 0001850119 · <br>Emerging growth company
Century Therapeutics, Inc.
Sign in to watch- Ticker
- IPSC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 842040295
- Phone
- 215-981-4000
- Business address
- 25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
- 4 Open-market sale See Remarks sold 524 shares at $2.11 ($1,106)
- 4 Open-market sale SVP Finance & Operations sold 249 shares at $2.11 ($526)
- 4 Shares withheld for taxes President and CEO gave up 463 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 31,172 shares (to pay taxes)
- 4 Open-market sale SVP Finance & Operations sold 264 shares at $2.34 ($618)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,365 shares (to pay taxes)
- 4 Open-market sale SVP Finance & Operations sold 7,043 shares at $2.55 ($17,953)
- 4 Open-market sale See Remarks sold 10,076 shares at $2.55 ($25,684)
- 4 Shares withheld for taxes President and CEO gave up 55,397 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,431 shares (to pay taxes)
- 4 Open-market sale See Remarks sold 479 shares at $2.54 ($1,215)
- 4 Open-market sale SVP Finance & Operations sold 247 shares at $2.54 ($626)
- 4 Shares withheld for taxes President and CEO gave up 463 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 31,172 shares (to pay taxes)
- 4 Open-market sale SVP Finance & Operations sold 323 shares at $1.82 ($589)
- 4 Grant or award President and CEO acquired 475,000 shares (grant or award)
- 4 Grant or award See Remarks acquired 135,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 135,000 shares (grant or award)
Page 2 of 10 · 188 filings